From the Journals

Managing pediatric heme/onc departments during the pandemic


 

FROM THE LANCET HAEMATOLOGY

Caring for patients with COVID-19

For inpatients diagnosed with COVID-19, Dr. He and colleagues recommended the following:

  • Prioritize COVID-19 treatment for children with primary disease remission.
  • For children not in remission, prioritize treatment for critical patients.
  • Isolated patients should be treated for COVID-19, and their chemotherapy should be temporarily suspended or reduced in intensity..

Dr. He and colleagues noted that, by following these recommendations for infection prevention, they had no cases of COVID-19 among children in their hematology/oncology departments. However, the authors said the recommendations “could fail to some extent” based on “differences in medical resources, health care settings, and the policy of the specific government.”

The authors said their recommendations should be updated continuously as new information and clinical evidence emerges.

Dr. He and colleagues reported having no conflicts of interest.

SOURCE: He Y et al. Lancet Haematol. doi: 10/1016/s2352-3026(20)30104-6.

Pages

Recommended Reading

Immunosuppression often triggers skin side effects
AVAHO
Stem cell transplant after CAR T cells may reduce B-ALL relapse risk
AVAHO
ALL chemotherapy looks effective in mixed phenotype leukemia
AVAHO
President Trump calls for end to HIV/AIDS, pediatric cancer
AVAHO
Genetic variant increases stroke risk in childhood cancer survivors
AVAHO
BRCA2 mutations linked to childhood NHL
AVAHO
Maintaining cancer care in the face of COVID-19
AVAHO
Advice from the front lines: How cancer centers can cope with COVID-19
AVAHO
Conducting cancer trials amid the COVID-19 pandemic
AVAHO